SCHEMBL12190840

SCHEMBL12190840

c1cc(N2c3ccccc3Cc3ccccc32)cc(N2c3ccccc3Cc3ccccc32)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.55
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
CASP6 P55212 2/20 0.40
FAAH O00519 1/20 0.40
MGLL Q99685 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 2/20 0.39
SLC6A2 P23975 3/20 0.35
PKM P14618 1/20 0.35
TLR9 Q9NR96 1/20 0.35
NOTUM Q6P988 1/20 0.35
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
DRD3 P35462 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12190838 0.91 HPGD (0.53) HPGDADRA2AADRA2BADRA2CMEN1
SCHEMBL6024338 0.87 MEN1 (0.56) HPGDMEN1KMT2ATLR9DRD2
SCHEMBL28150123 0.87 MGLL (0.49) HPGDADRA2AADRA2BADRA2CCASP6
SCHEMBL13651337 0.87 MEN1 (0.55) HPGDCASP6MGLLMEN1KMT2A
SCHEMBL30420919 0.86 HPGD (0.70) HPGDADRA2AADRA2BADRA2CMGLL
SCHEMBL496672 0.86 HPGD (0.70) HPGDADRA2AADRA2BADRA2CMGLL
SCHEMBL17955515 0.85 KDM4E (0.47) HPGDADRA2AADRA2BADRA2CCASP6
SCHEMBL17951467 0.84 HPGD (0.68) HPGDADRA2AADRA2BADRA2CMGLL
SCHEMBL6123772 0.84 HPGD (0.61) HPGDADRA2AADRA2BADRA2CMEN1
SCHEMBL6123767 0.83 HPGD (0.61) HPGDADRA2AADRA2BADRA2CMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048155-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC COMPONENTS cynora GmbH (DE) 2016-07-27 EP disclosed
EP-3048156-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC COMPONENTS cynora GmbH (DE) 2016-07-27 EP disclosed
US-8029919-B2 Phenothiazines, S-oxides, and S,S-dioxides as well as phenoxazines as emitters for OLEDs BASF AKTIENGESELLSCHAFT (DE) 2011-10-04 US disclosed
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds BASF AKTIENGESELLSCHAFT (DE) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308714-A1 Phenothiazines, S-Oxides, And S,S-Dioxides As Well As Phenoxazines As Emitters For Oleds PPOX, SMOX, SORD HPGD 340/4885ADRA2A 464/4885ADRA2B 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.